Avery W. Catlin
2017
In 2017, Avery W. Catlin earned a total compensation of $194K as Former Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 78% decrease compared to previous year.
Compensation breakdown
| Salary | $190,281 |
|---|---|
| Other | $3,728 |
| Total | $194,009 |
Catlin received $190.3K in salary, accounting for 98% of the total pay in 2017.
Catlin also received $3.7K in other compensation.
Rankings
In 2017, Avery W. Catlin's compensation ranked 14,074th out of 14,666 executives tracked by ExecPay. In other words, Catlin earned more than 4.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,074 out of 14,666 | 4th |
Division Manufacturing | 5,523 out of 5,768 | 4th |
Major group Chemicals And Allied Products | 1,982 out of 2,074 | 4th |
Industry group Drugs | 1,652 out of 1,730 | 5th |
Industry In Vitro and In Vivo Diagnostic Substances | 69 out of 72 | 4th |
Source: SEC filing on April 30, 2018.
Catlin's colleagues
We found six more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2017.
2017
Anthony Marucci
Celldex Therapeutics
Chief Executive Officer
2017
Tibor Keler
Celldex Therapeutics
Chief Scientific Officer
2017
Thomas Davis
Celldex Therapeutics
Chief Medical Officer
2017
Elizabeth Crowley
Celldex Therapeutics
Senior Vice President and Chief Product Development Officer
2017
Richard Wright
Celldex Therapeutics
Senior Vice President and Chief Commercial Officer
2017
Sam Martin
Celldex Therapeutics